You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glasdegib

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Orange, California
  • +2 more
Nov 30, 2022

Acute Myeloid Leukemia Trial in Heidelberg (Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib)

Terminated
  • Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin 147
  • +3 more
  • Heidelberg, Baden-Württemberg, Germany
    University Hospital Heidelberg, Internal Medicine V
Jun 27, 2022

Sclerodermoid Chronic GVHD (Disorder) Trial in Spain (Glasdegib)

Active, not recruiting
  • Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
  • Glasdegib
  • Barcelona, Spain
  • +5 more
Mar 16, 2022

Glioblastoma Trial in Spain (PF-04449913, Temozolomide Oral Capsule)

Active, not recruiting
  • Glioblastoma
  • Badalona, Barcelona, Spain
  • +7 more
Feb 16, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Worldwide (Glasdegib, Azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Salzburg, Austria
  • +17 more
Dec 14, 2022

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)

Terminated
Has Results
  • ACUTE MYELOID LEUKEMIA
  • New Haven, Connecticut
    Yale Cancer Center/Smilow
Sep 18, 2021

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +17 more
Oct 4, 2022

Acute Myeloid Leukemia Real World Treatment Patterns

Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
Feb 16, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (glasdegib, daunorubicin + cytarabine, azacitidine)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • glasdegib
  • +5 more
  • Los Angeles, California
  • +148 more
Jan 24, 2022

Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Nagoya, Aichi, Japan
  • +8 more
Jan 12, 2022

Renal Impairment Trial in Miami, Saint Paul (Glasdegib single 100 mg dose in normal healthy subjects, Glasdegib single 100 mg

Completed
  • Renal Impairment
  • Glasdegib single 100 mg dose in normal healthy subjects
  • +2 more
  • Miami, Florida
  • +2 more
Aug 27, 2019

Healthy Volunteers Trial in Brussels (Glasdegib Therapeutic Exposure, Glasdegib Supra-therapeutic Exposure, Positive Control

Completed
  • Healthy Volunteers
  • Glasdegib Therapeutic Exposure
  • +3 more
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Sep 3, 2019

Hepatic Impairment Trial in Miami, Orlando (Glasdegib 100 mg single oral dose)

Completed
  • Hepatic Impairment
  • Glasdegib 100 mg single oral dose
  • Miami, Florida
  • +2 more
May 3, 2019

Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

Completed
Has Results
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • Aurora, Colorado
  • +1 more
Dec 30, 2021

Glioblastoma Trial in Spain (TN-TC11G, Temozolomide Oral Product, Radiotherapy)

Not yet recruiting
  • Glioblastoma
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +7 more
Aug 2, 2022

Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis Trial in Japan, United

Terminated
Has Results
  • Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
  • Glasdegib (PF-04449913)
  • Placebo
  • Phoenix, Arizona
  • +18 more
Dec 26, 2018

Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +80 more
Feb 19, 2020

Healthy Volunteer Study Trial in New Haven (Glasdegib Oral Tablet, Glasdegib IV infusion)

Completed
  • Healthy Volunteer Study
  • Glasdegib Oral Tablet
  • Glasdegib IV infusion
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Nov 2, 2017

Healthy Volunteers Trial in New Haven (Glasdegib, High Fat, High Calorie Meal, Rabeprazole)

Completed
  • Healthy Volunteers
  • Glasdegib
  • +2 more
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Jul 28, 2017

Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapse Trial in

Unknown status
  • Acute Lymphoblastic Leukemia Recurrent
  • +4 more
  • INA03 administration
  • Marseille, Bouches-du Rhône, France
  • +1 more
Feb 4, 2020

Healthy Volunteers Trial in New Haven (Glasdegib, Rifampin)

Completed
  • Healthy Volunteers
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jun 24, 2015